KRYS (Krystal Biotech, Inc.) operates in the Health technology sector. It's currently trading at $369.86. Our composite momentum score rates it 70/110 based on price +5.7% (1d) — solid move, rvol 1.7x — elevated volume, rsi 71.4 — overbought, roc9 +11.0% — sharp acceleration, macd 9.7 — strong bullish crossover, and analyst: strong buy. Up 8.3% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.